Cargando...

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors

This study uses wholesale medication acquisition costs and Medicare claims data to assess how prices of existing tumor necrosis factor inhibitors changed in response to the market entry of new tumor necrosis factor inhibitors.

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Intern Med
Main Authors: San-Juan-Rodriguez, Alvaro, Prokopovich, Max V., Shrank, William H., Good, Chester B., Hernandez, Inmaculada
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503568/
https://ncbi.nlm.nih.gov/pubmed/30776053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.7656
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!